These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 10845111)
1. Insights from mouse models into the molecular basis of neurodegeneration. Heintz N; Zoghbi HY Annu Rev Physiol; 2000; 62():779-802. PubMed ID: 10845111 [TBL] [Abstract][Full Text] [Related]
2. [Animal models of neurodegenerative diseases]. Langui D; Lachapelle F; Duyckaerts C Med Sci (Paris); 2007 Feb; 23(2):180-6. PubMed ID: 17291428 [TBL] [Abstract][Full Text] [Related]
3. Neurodegeneration in Lurcher mice caused by mutation in delta2 glutamate receptor gene. Zuo J; De Jager PL; Takahashi KA; Jiang W; Linden DJ; Heintz N Nature; 1997 Aug; 388(6644):769-73. PubMed ID: 9285588 [TBL] [Abstract][Full Text] [Related]
4. GluR delta 2 and the development and death of cerebellar Purkinje neurons in lurcher mice. Heintz N; De Jager PL Ann N Y Acad Sci; 1999 Apr; 868():502-14. PubMed ID: 10414327 [TBL] [Abstract][Full Text] [Related]
5. The Lurcher mouse: fresh insights from an old mutant. Vogel MW; Caston J; Yuzaki M; Mariani J Brain Res; 2007 Apr; 1140():4-18. PubMed ID: 16412991 [TBL] [Abstract][Full Text] [Related]
6. TRAIL-related death receptors in normal, Lurcher and weaver mutant mouse brain. Bäurle J; Frischmuth S; Kranda K Neurosci Lett; 2004 Nov; 372(1-2):46-51. PubMed ID: 15531086 [TBL] [Abstract][Full Text] [Related]
7. Cell cycle events in neurons. Proliferation or death? Zhu X; Raina AK; Smith MA Am J Pathol; 1999 Aug; 155(2):327-9. PubMed ID: 10433924 [No Abstract] [Full Text] [Related]
8. Transgenic mouse models of neurodegenerative disease caused by CAG/polyglutamine expansions. Bates GP; Davies SW Mol Med Today; 1997 Nov; 3(11):508-15. PubMed ID: 9430787 [TBL] [Abstract][Full Text] [Related]
9. Genetic mouse models of neurodegenerative diseases. Trancikova A; Ramonet D; Moore DJ Prog Mol Biol Transl Sci; 2011; 100():419-82. PubMed ID: 21377633 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of T-type calcium channels in P/Q-type calcium channel mutant mice with ataxia and absence epilepsy. Nahm SS; Jung KY; Enger MK; Griffith WH; Abbott LC J Neurobiol; 2005 Feb; 62(3):352-60. PubMed ID: 15514988 [TBL] [Abstract][Full Text] [Related]
12. The ins and outs of a polyglutamine neurodegenerative disease: spinocerebellar ataxia type 1 (SCA1). Orr HT Neurobiol Dis; 2000 Jun; 7(3):129-34. PubMed ID: 10860780 [TBL] [Abstract][Full Text] [Related]
13. What transgenic mice tell us about neurodegenerative disease. Gurney ME Bioessays; 2000 Mar; 22(3):297-304. PubMed ID: 10684590 [TBL] [Abstract][Full Text] [Related]
14. Drain development, VIII: the reeler mouse. Lombroso PJ; Goldowitz D Am J Psychiatry; 1998 Dec; 155(12):1660. PubMed ID: 9842772 [No Abstract] [Full Text] [Related]
15. The appropriateness of the mouse model for ataxia-telangiectasia: neurological defects but no neurodegeneration. Lavin MF DNA Repair (Amst); 2013 Aug; 12(8):612-9. PubMed ID: 23731731 [TBL] [Abstract][Full Text] [Related]
16. Developmental expression of neuronal nitric oxide synthase in P/Q-type voltage-gated calcium ion channel mutant mice, leaner and tottering. Frank-Cannon TC; Zeve DR; Abbott LC Brain Res; 2007 Apr; 1140():96-104. PubMed ID: 16359645 [TBL] [Abstract][Full Text] [Related]